During the last funding period, the applicant has made a number of published as well as preliminary observations that suggest: 1) c-Myc mediated anchorage independent growth of rat fibroblast is associated with the deregulated expression of genes including cyclin A, ornithine decarboxylase and several genes that he has cloned and are as yet undefined, 2) Deregulated cyclin A expression induces anchorage independent growth and apoptosis of rat fibroblasts, 3) Chromosomal localization of the MXI-1 gene and loss of heterozygosity studies suggest that MXI-1 is a tumor suppressor gene in human prostate cancer and glioblastomas, and 4) TNFb (lymphotoxin) selectively induces apoptosis in Myc- overexpressing fibroblasts. A unique, rapid and efficient model and systematic approach to identify c-Myc responsive genes has been established. Based on these observations and to reach the long term goal of delineating the mechanisms by which c-Myc transform cells, experiments are proposed to answer the following questions: 1) What are the genes that are upregulated by c-Myc, and how do they contribute to neoplasia? 2) What are the genes that are downregulated by c-Myc and how do they participate in neoplasia? 3) What are the effects of Mxi-1 on the expression of c-Myc target genes? and 4) Which c-Myc target genes predispose fibroblasts to lymphotoxin-mediated apoptosis, and is this pathway exploitable for therapeutic purposes?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA057341-07
Application #
2748736
Study Section
Special Emphasis Panel (ZRG2-MEP (01))
Program Officer
Gallahan, Daniel L
Project Start
1992-09-01
Project End
2000-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
7
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Malik, Dania M; Rhoades, Seth; Weljie, Aalim (2018) Extraction and Analysis of Pan-metabolome Polar Metabolites by Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS). Bio Protoc 8:
Yuan, Jiao; Hu, Zhongyi; Mahal, Brandon A et al. (2018) Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. Cancer Cell 34:549-560.e9
Wolpaw, Adam J; Dang, Chi V (2018) Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy. Trends Cell Biol 28:201-212
Walton, Zandra E; Patel, Chirag H; Brooks, Rebekah C et al. (2018) Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR. Cell 174:72-87.e32
Dang, Chi Van; Kim, Jung-Whan (2018) Convergence of Cancer Metabolism and Immunity: an Overview. Biomol Ther (Seoul) 26:4-9
Lu, Yunqi; Hu, Zhongyi; Mangala, Lingegowda S et al. (2018) MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels. Cancer Res 78:64-74
Xie, Hong; Tang, Chih-Hang Anthony; Song, Jun H et al. (2018) IRE1? RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers. J Clin Invest 128:1300-1316
Krishnaiah, Saikumari Y; Wu, Gang; Altman, Brian J et al. (2017) Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism. Cell Metab 25:961-974.e4
Dang, Chi V (2017) c-MYC mRNA tail tale about glutamine control of transcription. EMBO J 36:1806-1808
Dang, Chi V (2017) MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Curb Gemcitabine Resistance in Pancreatic Cancer. Cancer Cell 32:3-5

Showing the most recent 10 out of 90 publications